Annual EBITDA
$1.21B$420.00M-25.80%
Summary
- Current Value
- As of today, SOLV annual EBITDA is $1.21B, down -25.80% on
- Historical Performance
- SOLV annual EBITDA is down -46.81% over the past 3 years, down -40.46% over the past 5 years
- All-Time High Comparison
- SOLV annual EBITDA is currently -51.21% below its historical high of $2.48B set on
- 3-Year Low Comparison
- SOLV annual EBITDA is at its 3-year low
- Sector Comparison
- SOLV annual EBITDA is higher than 93.82% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.21B | -25.8% | -46.8% | -40.5% | -40.5% | |
| Quarterly EBITDA | $249.00M | -20.4% | -51.2% | -55.9% | -55.9% | |
| TTM EBITDA | $1.46B | +2.0% | -9.4% | +158.1% | +158.1% | |
| Price | $74.12 | +5.5% | – | – | – | |
| PE Ratio | 9.08 | -71.9% | – | – | – | |
| Annual Revenue | $8.33B | +0.9% | +2.4% | +14.3% | +14.3% | |
| Annual EPS | $8.88 | +221.9% | +14.2% | +34.7% | +34.7% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Annual Net Income | $1.56B | +224.8% | +15.9% | +36.7% | +36.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.27B | N/A | -46.8% |
| 5Y | $2.48B | -51.2% | |
| All | $2.48B | -51.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.21B | at low | |
| 5Y | $1.21B | at low | |
| All | $1.21B | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $1.21B | -25.8% | |
| $1.63B | -27.7% | |
| $2.25B | -0.8% |
| Year | Value | Change |
|---|---|---|
| $2.27B | -8.3% | |
| $2.48B | +22.0% | |
| $2.03B | - |
FAQ
What is the current annual EBITDA of SOLV?
As of today, SOLV annual EBITDA is $1.21B
What is 1-year change in SOLV annual EBITDA?
SOLV annual EBITDA is down -25.80% year-over-year
What is 3-year change in SOLV annual EBITDA?
SOLV annual EBITDA is down -46.81% over the past 3 years
How far is SOLV annual EBITDA from its all-time high?
SOLV annual EBITDA is currently -51.21% below its historical high of $2.48B set on December 1, 2021
How does SOLV annual EBITDA rank versus sector peers?
SOLV annual EBITDA is higher than 93.82% of companies in Healthcare sector
When is SOLV next annual earnings release?
As of today, the next annual earnings release for SOLV has not been scheduled
Quarterly EBITDA
$249.00M$53.00M-17.55%
Summary
- Current Value
- As of today, SOLV quarterly EBITDA is $249.00M, down -17.55% on
- Historical Performance
- SOLV quarterly EBITDA is down -20.45% year-over-year, down -51.18% over the past 3 years
- All-Time High Comparison
- SOLV quarterly EBITDA is currently -61.57% below its historical high of $648.00M set on
- 3-Year Low Comparison
- SOLV quarterly EBITDA is at its 3-year low
- Sector Comparison
- SOLV quarterly EBITDA is higher than 92.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $249.00M | -17.6% | -20.4% | -51.2% | -55.9% | |
| Annual EBITDA | $1.21B | – | -25.8% | -46.8% | -40.5% | |
| TTM EBITDA | $1.46B | -4.2% | +2.0% | -9.4% | +158.1% | |
| Price | $74.12 | -9.0% | +5.5% | – | – | |
| PE Ratio | 9.08 | -1.1% | -71.9% | – | – | |
| Quarterly Revenue | $2.01B | +0.4% | -3.1% | -0.3% | -0.1% | |
| Quarterly EPS | $0.07 | -80.5% | -91.1% | -95.9% | -96.4% | |
| $114.00M | -40.3% | -38.0% | -68.8% | -73.0% | ||
| Quarterly Net Income | $13.00M | -79.4% | -90.5% | -95.6% | -96.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $622.00M | -60.0% | |
| 3Y | $648.00M | -61.6% | |
| 5Y | $648.00M | -61.6% | |
| All | $648.00M | -61.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $249.00M | at low | |
| 3Y | $249.00M | at low | |
| 5Y | $249.00M | at low | |
| All | $249.00M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of SOLV?
As of today, SOLV quarterly EBITDA is $249.00M
What is SOLV quarterly EBITDA most recent change?
SOLV quarterly EBITDA was down -17.55% on March 31, 2026
What is 1-year change in SOLV quarterly EBITDA?
SOLV quarterly EBITDA is down -20.45% year-over-year
How far is SOLV quarterly EBITDA from its all-time high?
SOLV quarterly EBITDA is currently -61.57% below its historical high of $648.00M set on September 30, 2023
How does SOLV quarterly EBITDA rank versus sector peers?
SOLV quarterly EBITDA is higher than 92.69% of companies in Healthcare sector
When is SOLV next earnings release?
The next earnings release for SOLV is on
TTM EBITDA
$1.46B$64.00M-4.20%
Summary
- Current Value
- As of today, SOLV TTM EBITDA is $1.46B, down -4.20% on
- Historical Performance
- SOLV TTM EBITDA is up +2.03% year-over-year, down -9.44% over the past 3 years
- All-Time High Comparison
- SOLV TTM EBITDA is currently -35.57% below its historical high of $2.26B set on
- 3-Year Low Comparison
- SOLV TTM EBITDA is +2.03% above its 3-year low of $1.43B reached on
- Sector Comparison
- SOLV TTM EBITDA is higher than 94.17% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.46B | -4.2% | +2.0% | -9.4% | +158.1% | |
| Annual EBITDA | $1.21B | – | -25.8% | -46.8% | -40.5% | |
| Quarterly EBITDA | $249.00M | -17.6% | -20.4% | -51.2% | -55.9% | |
| Price | $74.12 | -9.0% | +5.5% | – | – | |
| PE Ratio | 9.08 | -1.1% | -71.9% | – | – | |
| TTM Revenue | $8.28B | -0.8% | -0.3% | +37.5% | +312.3% | |
| TTM EPS | $8.16 | -8.0% | +276.0% | +50.7% | +320.7% | |
| $976.00M | -6.7% | +10.2% | -16.7% | +130.7% | ||
| TTM Net Income | $1.43B | -8.0% | +278.8% | +53.2% | +327.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.67B | -12.9% | |
| 3Y | $2.26B | -35.6% | |
| 5Y | $2.26B | -35.6% | |
| All | $2.26B | -35.6% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.43B | N/A | +2.0% |
| 3Y | $1.43B | +2.0% | |
| 5Y | $565.00M | +158.1% | |
| All | $565.00M | +158.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of SOLV?
As of today, SOLV TTM EBITDA is $1.46B
What is SOLV TTM EBITDA most recent change?
SOLV TTM EBITDA was down -4.20% on March 31, 2026
What is 1-year change in SOLV TTM EBITDA?
SOLV TTM EBITDA is up +2.03% year-over-year
How far is SOLV TTM EBITDA from its all-time high?
SOLV TTM EBITDA is currently -35.57% below its historical high of $2.26B set on March 31, 2024
How does SOLV TTM EBITDA rank versus sector peers?
SOLV TTM EBITDA is higher than 94.17% of companies in Healthcare sector
When is SOLV next earnings release?
The next earnings release for SOLV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- SOLV Official Website www.solventum.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.htm
- SOLV Profile on Yahoo Finance finance.yahoo.com/quote/SOLV
- SOLV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/solv